[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350074-105":59,"doc-detail-350074-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-regulation-and-function-of-hippoyap-pathway-in-cancer","The Regulation and Function of Hippo/YAP Pathway in Cancer","","The Hippo/YAP signaling pathway orchestrates organ size control, tissue homeostasis, cell proliferation, and cell polarity. Dysregulated Hippo/YAP signaling drives the initiation and progression of multiple cancers, positioning the pathway as a promising therapeutic target. Despite encouraging preclinical results, clinical translation remains limited due to incomplete knowledge of upstream regulators, downstream effectors, cross-talk among pathways, and tumor-type specific roles. The review consolidates current components, mechanisms, miRNA/lncRNA modulation, and emerging Hippo/YAP-directed therapies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-regulation-and-function-of-hippoyap-pathway-in-cancer/350074/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-regulation-and-function-of-hippoyap-pathway-in-cancer/350074.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is the Hippo/YAP pathway considered a therapeutic target in cancer?","Question",{"text":112,"@type":113},"Aberrant Hippo/YAP signaling contributes to the initiation and progression of multiple cancers, making it a promising therapeutic target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What limits clinical translation of Hippo/YAP-targeting agents?",{"text":117,"@type":113},"Clinical translation is limited by insufficient understanding of upstream regulators, downstream effectors, pathway crosstalk, and context-dependent roles across tumor types.",{"name":119,"@type":110,"acceptedAnswer":120},"How does Hippo activation affect YAP/TAZ activity?",{"text":121,"@type":113},"When the Hippo pathway is activated, YAP/TAZ are phosphorylated and retained in the cytoplasm, which prevents YAP/TAZ-driven transcription in the nucleus.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350074,1790900574,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","The FASEB Journal  \nThe Regulation and Function of Hippo/YAP Pathway in Cancer  \nChinmoy Ghosh1 | Ruchi Kakar1 | Seline Torkamboor1 | Yue Sun1,2   \n1Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth  \nUniversity, Richmond, Virginia, USA | 2Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA Correspondence: Yue Sun ([ysun4@vcu.edu](ysun4@vcu.edu))  \nReceived: 3 December 2025 | Revised: 26 February 2026 | Accepted: 24 March 2026  \nKeywords: cancer | ferroptosis | hippo pathway | lncRNA | microRNA | TEADs | YAP/TAZ | Yki  \nABSTRACT  \nThe Hippo/YAP signaling pathway is a key regulatory network that governs organ size, tissue homeostasis, cell proliferation, and cell polarity. Aberrant Hippo/YAP signaling contributes to the initiation and progression of multiple cancers, making this pathway an attractive therapeutic target. Although several agents targeting Hippo/YAP have shown promise in preclinical models, clinical translation has been limited. These challenges likely stem from an incomplete understanding of the upstream regulators, downstream effectors, pathway crosstalk, and context-dependent roles of Hippo/YAP across different tumor types. Continued mechanistic investigation is required to clarify these complexities and reveal new therapeutic vulnerabilities. In this review, we summarize the current knowledge of the core components of the Hippo/YAP pathway, its regulatory mechanisms and interactions with other signaling cascades, its dysregulation in cancer, the involvement of microRNAs and lncRNAs in pathway modulation, and emerging therapeutic strategies targeting Hippo/YAP.  \n1 | Introduction  \nThe Hippo pathway is a highly conserved signaling cascade that regulates a broad range of biological processes, including cell survival, differentiation, organ size, tissue homeostasis, and tumor progression, by modulating key target genes [1, 2] . The pathway was first discovered in Drosophila as a central mechanism controlling tissue growth [1] . Canonically, the Hippo pathway consists of the Hippo (Hpo) serine/threonine kinase, Salvador (SAV1), the adaptor protein Mob as tumor suppressor (Mats), the serine/threonine kinase Warts (Wts; also known as large tumor suppressor, Lats), and the transcriptional coactivator Yorkie (Yki) (Figure 1). Activation of Hpo by upstream stimuli (e.g., TAOK1/2/3) induces the “Hippo-on” state, in which the Hpo-Mats complex phosphorylates and activates Wts [3–6] . Wts, in turn, phosphorylates key serine residues on Yki [5, 7], promoting its sequestration in the cytoplasm by 14-3-3 proteins and thereby preventing Yki-mediated transcriptional activation (Figure 1) . In the absence of Hpo activation (“Hippo-off”), Yki  \nis not retained by 14-3-3 and can translocate into the nucleus to partner with the transcription factor Scalloped, driving expression of target genes [5, 7–9] . Since its discovery in Drosophila, homologous components of the Hippo pathway have been identified in mammals, including MST1/2 (orthologs of Hpo), SAV1 (ortholog of Salvador), LATS1/2 (orthologs of Wts), MOB1A/B (orthologs of Mats), Yes-associated protein (YAP), and its paralog TAZ (orthologs of Yki) .  \nSimilar to Drosophila, activation of the Hippo pathway in mammals prevents the nuclear translocation of YAP/TAZ, thereby limiting their transcriptional activity and restraining uncontrolled cell proliferation [10] . Under conditions lacking growth factors, the Hippo pathway is normally “on.” In this state, MST1/2 kinases associate with LATS1/2 and the adaptor protein SAV1, resulting in LATS1/2-mediated phosphorylation of YAP (Ser127) and TAZ (Ser89) . These phosphorylation events promote binding to 14-3-3 proteins, retaining YAP/TAZ in the cytoplasm and preventing their entry into the nucleus [11, 12] .  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, whi","cbCailtLHYa0HpOx","https://ap.wps.com/l/cbCailtLHYa0HpOx","pdf",3165916,21,"English","# Introduction\n## Core components and activation states of Hippo/YAP signaling\n## Upstream stimuli and regulation by growth factor pathways","[{\"question\":\"Why is the Hippo/YAP pathway considered a therapeutic target in cancer?\",\"answer\":\"Aberrant Hippo/YAP signaling contributes to the initiation and progression of multiple cancers, making it a promising therapeutic target.\"},{\"question\":\"What limits clinical translation of Hippo/YAP-targeting agents?\",\"answer\":\"Clinical translation is limited by insufficient understanding of upstream regulators, downstream effectors, pathway crosstalk, and context-dependent roles across tumor types.\"},{\"question\":\"How does Hippo activation affect YAP/TAZ activity?\",\"answer\":\"When the Hippo pathway is activated, YAP/TAZ are phosphorylated and retained in the cytoplasm, which prevents YAP/TAZ-driven transcription in the nucleus.\"}]","The Regulation and Function of Hippo/YAP Pathway in Cancer | PDF",1790087032,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b0f12d52bf562c340f59861ec84b52f.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cc9944b257d2cb36f78b87a84c7b80c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfd804b65cdb63f22137575782e1bd15.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa37ecc001a0603100348f5d717f2f93.webp",980,1287]